共 26 条
- [21] Very-low-dose decitabine treatment for patients with intermediate- or high-risk myelodysplastic syndrome: a retrospective analysis of thirteen cases[J]. ANNALS OF HEMATOLOGY, 2020, 99 (11) : 2539 - 2546Zhang, Kaiji论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaLian, Ying论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaGuan, Xiaohong论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaHu, Qian论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaLei, Lihua论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaTao, Li论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaHe, Dong论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaLin, Juan论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaHou, Zheng论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaRen, Lirong论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaLiu, Xiaoxiao论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaRen, Qian论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaPan, Lin论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaFei, Xiaoli论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaXiong, Mei论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaWen, Shunzhu论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R ChinaCao, Jinzhu论文数: 0 引用数: 0 h-index: 0机构: Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China Chengdu First Peoples Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China
- [22] MUTATION ANALYSIS BY TARGETED NEXT GENERATION SEQUENCING IN ULTRA HIGH RISK CLL PATIENTS TREATED WITHIN THE CLL2O STUDY[J]. HAEMATOLOGICA, 2016, 101 : 228 - 229Estenfelder, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Internal Med 3, Ulm, Germany Univ Ulm, Internal Med 3, Ulm, GermanyTausch, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Internal Med 3, Ulm, Germany Univ Ulm, Internal Med 3, Ulm, GermanyHuber, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Internal Med 3, Ulm, Germany Univ Ulm, Internal Med 3, Ulm, Germany论文数: 引用数: h-index:机构:Cymbalista, F.论文数: 0 引用数: 0 h-index: 0机构: Hop Avicenne, Serv Hematol Biol, Bobigny, France Univ Ulm, Internal Med 3, Ulm, GermanyLeblond, V.论文数: 0 引用数: 0 h-index: 0机构: Hop La Pitie Salpetriere, Serv Hematol, Paris, France Univ Ulm, Internal Med 3, Ulm, GermanyDelmer, A.论文数: 0 引用数: 0 h-index: 0机构: CHU Reims, Serv Hematol Clin, Reims, France Univ Ulm, Internal Med 3, Ulm, GermanyIbach, S.论文数: 0 引用数: 0 h-index: 0机构: WISP GmbH, Langenfeld, Germany Univ Ulm, Internal Med 3, Ulm, GermanyChoquet, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Internal Med 3, Ulm, GermanyDartigeas, C.论文数: 0 引用数: 0 h-index: 0机构: CHU Tours, Serv Oncol & Hematol, Tours, France Univ Ulm, Internal Med 3, Ulm, GermanyCazin, B.论文数: 0 引用数: 0 h-index: 0机构: CHU Claude Huriez, Serv Malad Sang, Lille, France Univ Ulm, Internal Med 3, Ulm, GermanyTournilhac, O.论文数: 0 引用数: 0 h-index: 0机构: Univ Auvergne EA3846, Inserm CIC 501, Hop Estaing, Serv Therapie Cellulaire & Hematol,Clin Adulte, Clermont Ferrand, France Univ Ulm, Internal Med 3, Ulm, GermanyPegourie, B.论文数: 0 引用数: 0 h-index: 0机构: CHU Grenoble, Serv Hematol, Grenoble, France Univ Ulm, Internal Med 3, Ulm, GermanySeiler, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Munich, Med Klinik & Poliklin 3, Munich, Germany Univ Ulm, Internal Med 3, Ulm, GermanySoekler, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Tubingen, Internal Med 2, Tubingen, Germany Univ Ulm, Internal Med 3, Ulm, GermanyZirlik, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, Hamatol & Onkol, Innere Med 1, Freiburg, Germany Univ Ulm, Internal Med 3, Ulm, GermanyAlt, J.论文数: 0 引用数: 0 h-index: 0机构: Johannes Gutenberg Univ Mainz, Med Klin Hamatol Onkol 3, Mainz, Germany Univ Ulm, Internal Med 3, Ulm, GermanySchetelig, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany Univ Ulm, Internal Med 3, Ulm, Germany论文数: 引用数: h-index:机构:Dreger, P.论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, Internal Med 5, Heidelberg, Germany Univ Ulm, Internal Med 3, Ulm, GermanyDoehner, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Internal Med 3, Ulm, Germany Univ Ulm, Internal Med 3, Ulm, GermanyStilgenbauer, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Internal Med 3, Ulm, Germany Univ Ulm, Internal Med 3, Ulm, Germany
- [23] Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S350 - S350Garcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAWei, Andrew H.论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPorkka, Kimmo论文数: 0 引用数: 0 h-index: 0机构: Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKnapper, Steve论文数: 0 引用数: 0 h-index: 0机构: Cardiff Univ, Cardiff, Wales Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USATraer, Elie论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAScholl, Sebastian论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Jena, Jena, Germany Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAVey, Norbert论文数: 0 引用数: 0 h-index: 0机构: Inst Paoli Calmettes, Marseille, France Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAWermke, Martin论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Dresden, Dresden, Germany Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJanssen, Jeroen论文数: 0 引用数: 0 h-index: 0机构: Univ Amsterdam, Med Ctr, Locat VUmc, Amsterdam, Netherlands Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USANarayan, Rupa论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USALoo, Sun论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Melbourne, Vic, Australia Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USATovar, Natalia论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Barcelona, Spain Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKontro, Mika论文数: 0 引用数: 0 h-index: 0机构: Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA论文数: 引用数: h-index:机构:Naidu, Purushotham论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAOrlando, Elena论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPatel, Nidhi论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMakofske, Jessica论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMa, Fei论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAZhang, Na论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMohammed, Anisa论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USARinne, Mikael L.论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABorate, Uma论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABrunner, Andrew M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [24] Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall-and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R[J]. BLOOD, 2014, 124 (21)Schanz, Julie论文数: 0 引用数: 0 h-index: 0机构: Univ Med Gottingen, Gottingen, Germany Univ Med Gottingen, Gottingen, GermanyBraulke, Friederike论文数: 0 引用数: 0 h-index: 0机构: Univ Gottingen, D-37073 Gottingen, Germany Univ Med Gottingen, Gottingen, GermanyMufti, Ghulam J.论文数: 0 引用数: 0 h-index: 0机构: Kings Coll London, London WC2R 2LS, England Univ Med Gottingen, Gottingen, GermanyCrisa, Elena论文数: 0 引用数: 0 h-index: 0机构: Kings Coll London, London WC2R 2LS, England Univ Med Gottingen, Gottingen, GermanyKulasekararaj, Austin论文数: 0 引用数: 0 h-index: 0机构: Dept Haematol Med, London, England Univ Med Gottingen, Gottingen, GermanyNachtkamp, Kathrin论文数: 0 引用数: 0 h-index: 0机构: Univ Dusseldorf, Dusseldorf, Germany Univ Med Gottingen, Gottingen, GermanyGerming, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Dusseldorf, Dusseldorf, Germany Univ Med Gottingen, Gottingen, GermanySchmitz, Stefan论文数: 0 引用数: 0 h-index: 0机构: Gemeinschaftspraxis Hamatol & Onkol, Cologne, Germany Univ Med Gottingen, Gottingen, GermanyHaas, Peter论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, D-79106 Freiburg, Germany Univ Med Gottingen, Gottingen, GermanyLuebbert, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Freiburg, Freiburg, Germany Univ Med Gottingen, Gottingen, GermanyMueller-Thomas, Catharina论文数: 0 引用数: 0 h-index: 0机构: Tech Univ Munich, D-80290 Munich, Germany Univ Med Gottingen, Gottingen, GermanyGoetze, Katharina论文数: 0 引用数: 0 h-index: 0机构: Tech Univ Munich, D-80290 Munich, Germany Univ Med Gottingen, Gottingen, Germany论文数: 引用数: h-index:机构:Nolte, Florian论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany Univ Med Gottingen, Gottingen, GermanyHofmann, Wolf-Karsten论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany Univ Med Gottingen, Gottingen, GermanyHaase, Detlef论文数: 0 引用数: 0 h-index: 0机构: Univ Gottingen, D-37073 Gottingen, Germany Univ Med Gottingen, Gottingen, Germany
- [25] A phase II study of venetoclax (VEN) in combination with 10-day decitabine (DEC) in older/unfit pts with newly diagnosed (ND) or pts with relapsed/refractory (R/R) acute myeloid leukemia (AML), or high-risk myelodysplastic syndrome (HR-MDS).[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Swaminathan, Mahesh论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USADinardo, Courtney Denton论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMaiti, Abhishek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAPemmaraju, Naveen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAOhanian, Maro论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USADaver, Naval Guastad论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAGarcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAIssa, Ghayas C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USABorthakur, Gautam论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USARavandi-Kashani, Farhad论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMontalban-Bravo, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKadia, Tapan M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAValero, Yesid Alvarado论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAJabbour, Elias论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAShort, Nicholas James论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAWierda, William G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAJain, Nitin论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKornblau, Steven Mitchell论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKantarjian, Hagop M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKonopleva, Marina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
- [26] Very High Rate of Leukemic Transformation and Poor Survival in Patients with Lower Risk Myelodysplastic Syndrome (MDS) Who Dynamically Acquire FLT3 Molecular Alteration (FLT3m): Study of 290 MDS Patients with Sequential Mutation Analysis[J]. BLOOD, 2012, 120 (21)Takahashi, Koichi论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAJabbour, Elias J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAWang, Xuemei论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAGhanem, Hady论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAPemmaraju, Naveen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USARavandi, Farhad论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USACortes, Jorge E.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAFaderl, Stefan论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAKadia, Tapan M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USABorthakur, Gautam论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAWierda, William G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAPierce, Sherry A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAEstrov, Zeev论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAKantarjian, Hagop M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USAGarcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA